Pathology of intraductal papillary mucinous neoplasms

Naziheh Assarzadegan, Elizabeth Thompson, Kevan Salimian, Matthias M. Gaida, Lodewijk A.A. Brosens, Laura Wood, Syed Z. Ali, Ralph H. Hruban

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Intraductal papillary mucinous neoplasms (IPMNs) represent a unique opportunity to treat and prevent a curable neoplasm before it has the chance to progress to incurable cancer. This prospect, however, has to be balanced with the real risk of over treating patients with lesions that would, in fact, never progress during the life of the patient. Purpose: Informed clinical decisions in the treatment of IPMNs are first and foremost based on a deep understanding of the pathology of these lesions. Conclusions: Here we review the pathology of IPMNs, with an emphasis on the clinical relevance of the important features that characterize these lesions.

Original languageEnglish (US)
Pages (from-to)2643-2655
Number of pages13
JournalLangenbeck's Archives of Surgery
Volume406
Issue number8
DOIs
StatePublished - Dec 2021

Keywords

  • Intraductal oncocytic papillary neoplasm
  • Intraductal papillary mucinous neoplasm
  • Intraductal tubulopapillary neoplasm
  • Pancreas cancer
  • Pancreatic cancer
  • Pathology

ASJC Scopus subject areas

  • Surgery

Fingerprint

Dive into the research topics of 'Pathology of intraductal papillary mucinous neoplasms'. Together they form a unique fingerprint.

Cite this